Patent ID: 11896631
Assignee: ALFASIGMA S.P.A.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for treating and/or preventing and/or reducing symptoms associated with diverticulosis or diverticular diseases, the method comprising
administering to a patient in need thereof a probiotic composition comprising Lactobacillus paracasei DG in combination with bacteria, yeast, and/or further microorganisms, wherein said bacteria belong to at least one genus each genus selected from Lactobacillus, Bifidobacterium, Bacillus, Propionibacterium, Streptococcus, Lactococcus, Aerococcus, Enterococcus, and combinations thereof
wherein the at least one genus is Bifidobacterium, and the bacteria belong to at least one of the following species: B. animalis, B. bifidum, B. breve, B. infantis, B. longum, B. adolescentis, B. catenulatum, B. anqulatum, B. asteroides, B. bourn, B. choerinum, B. coryneforme, B. cuniculi, B. denticolens, B. dentium, B. gallicum, B. gallinarum, B. indicum, B. inopinatum, B. lactis, B. magnum, B. merycicum, B. minimum, B. pseudocatenulatum, B. pseudolongum, B. pullorum, B. ruminantium, B. saeculare, B. subtile, B. thermacidophilum, B. thermophilum and B. tsurumiense.